COULD AN INFECTION BE CAUSING YOUR PATIENT'S SYMPTOMS?
EDUCATIONAL SERIES ARCHIVE
Moleculera Labs provides medical professionals with an online educational series featuring the latest news, peer-reviewed journal articles, and video presentations on molecular mimicry and post-infectious autoimmune encephalopathies, including PANS and PANDAS.
If you are a healthcare provider and would like to receive email updates about our educational series, please click on the link below.
COVID-related syndrome MIS-C linked with cardiac complications in children
Case report: PANDAS and persistent Lyme disease with neuropsychiatric symptoms
Antineuronal biomarkers help diagnose encephalitis in children
COVID-19 viral infection may increase risk of neuropsychiatric sequelae
Lyme disease and the immune system: elevated neuronal autoantibodies associated with persistent symptoms
Study demonstrates clinical value of the Cunningham Panel™ and accuracy in patients with symptoms of an autoimmune encephalopathy
Clinical manifestations and IVIG treatment success for PANDAS patients
Dr. Shimasaki discusses how the Cunningham Panel biomarkers help identify whether neuropsychiatric symptoms may be caused by an autoimmune condition.
Nationwide study finds both mild and severe infections can increase risk of mental disorders in children and adolescents.
Identifying T cell and B cell involvement in autoantibody-mediated movement disorders can assist in targeting treatment.
When immune cells and autoantibodies impact brain functioning
Autoimmune targets in Cunningham Panel predict IVIG treatment response in subset of autism patients
Cunningham Panel™ helps identify an autoimmune disorder in child initially diagnosed with schizophrenia
Watch 20/20 and Nightline full episodes on PANDAS
The Great Connection: Immune system activation + neuroinflammation = neurodegenerative diseases
Principles and Approaches to the Treatment of Immune-Mediated Movement Disorders
Course of Neuropsychiatric Symptoms After Introduction and Removal of Nonsteroidal Anti-Inflammatory Drugs: A Pediatric Observational Study
Pediatric Acute-Onset Neuropsychiatric Syndrome Response to Oral Corticosteroid Bursts
Treatment of Pediatric Acute-Onset Neuropsychiatric Disorder in a Large Survey Population
A Double-Blind Randomized Placebo-Controlled Pilot Study of Azithromycin in Youth with Acute-Onset Obsessive–Compulsive Disorder
The Journal Of Child And Adolescent Psychopharmacology Treatment Articles Temporary Free Access
Therapeutic Plasma Apheresis as a Treatment for 35 Severely Ill Children and Adolescents with Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections
Clinical Evaluation of Youth with Pediatric Acute-onset Neuropsychiatric Syndrome (PANS)
The National Institutes of Health (NIH) Clinical Center Grand Rounds features presentations on autoimmunity and acute-onset neuropsychiatric diseases
Dr. Madeleine Cunningham and colleagues discuss the association between Streptococcus pyogenes and tics/OCD
Physicians and researchers discuss options for patients suspected of having infection-mediated autoimmune neurologic conditions
Seeing Your First Patient with PANDAS/PANS provides an overview of Pediatric Acute-onset Neuropsychiatric Syndrome (PANS)
The PPN Diagnostic Flow Chart is a tool designed to help medical professionals navigate the process of evaluating and treating PANS/PANDAS patients.
A young boy from Oklahoma shares his emotional and heartwarming story with PANS/PANDAS
Group A Streptococcus intranasal infection promotes CNS infiltration by streptococcal-specific Th17 cells
Linking intranasal Group A Streptococcus infection to CNS complications
Autoimmunity against dopamine receptors in neuropsychiatric and movement disorders: a review of Sydenham chorea and beyond.
Use of Intravenous Immunoglobulin in the Treatment of Youths with Pediatric Autoimmune Neuropsychiatric Disorders
Recovery after proper diagnosis and treatment of postinfectious autoimmune encephalopathy
Molecular Mimicry as a Mechanism of Autoimmune Disease
Autoimmune Diseases and Severe Infections as Risk Factors for Mood Disorders: A Nationwide Study
MOLECULERA LABS EDUCATIONAL BROCHURES
Moleculera Labs has designed brochures for both parents and physicians to assist in making a Neuropsychiatric Disorder Diagnosis or a PANS/PANDAS diagnosis as well as a brochure answering frequently asked questions about insurance coverage for The Cunningham Panel™. As a healthcare provider, you may order brochures in bulk for your office and to handout to your patients. Click below to order or to download these brochures.